Official EU label nameGlossary entry 18549
OXYQUINOLINE SULFATE
This record confirms an official common ingredient name for EU cosmetic product labelling. It does not by itself confirm that the substance is permitted, unrestricted or safe.
Global evidence snapshot
The resolved identity has matching regulatory evidence in 9 of 13 indexed market datasets: 12 country records and 1 EU Annex records. Every result and evidence gap is listed below.
Markets checked
13
Markets with evidence
9
Evidence gaps
4
Resolved identifiers
4
A missing local match is not permission, approval or proof of safety. It means no strong identity match was resolved in that indexed dataset.
Resolved substance identity
CAS:134-31-6148-24-3
EC:205-137-1205-711-1
Ingredient index records:
OXYQUINOLINE SULFATE
Cosmetic functions: ANTIMICROBIAL, CHELATING
bis(8-Hydroxyquinolinium) sulphate
Inventory restriction note: II/395 III/51
13 matched or reported names
OXYQUINOLINE SULFATEoxyquinoline sulfatebis(8-hydroxyquinolinium) sulphateHydroxy-8-quinoline and its sulphate bis(8-hydroxyquinolinium) sulphate, except for the uses of the sulphate provided for in entry 51 of Annex IIIOxyqui-noline sulphate8-Hydroxyquinoline and its sulfateHydroxy-8-quinoline and its sulfate bis(8-hydroxyquinolinium) sulfate, except for the uses of the sulfate provided Schedule 5, entry 52Bis(8-hydroxyquinolium) sulfate (quinolin-8-ol sulfate)Quinolin-8-ol and bis (8- hydroxyquinolium) sulphate Oxyquinoline and Oxyquinoline Sulphate CAS No 148-24-3/134-31-68-羟基喹啉及其硫酸盐（化妆品限用组 分中的8-羟基喹啉硫酸盐除外） — Hydroxy-8-quinoline （CAS No. 148-24-3） and its sulfate （CAS No. 134-31-6）, except for the uses of the sulphate provided in restricted substances in cosmetics productsHidroxi-8-quinolina e seu sulfato, exceto os mencionados em outras listas deHydroxy-8-quinoline and its sulphate bis(8-hydroxyquinolinium) sulphate, except for the uses of the sulphate provided for in No 53 in Annex B (CAS No. 148-24-3/134-31-6)um) sulphate Oxyqui- noline sulphate (CAS No. /134-31-6)
Regulatory evidence in all 13 markets
Open each matched record for its scope, concentration, conditions, warnings and official source version.
Swipe or scroll horizontally to see dataset coverage and next actions.
| Market | Result | Records | Dataset | Meaning / next action |
|---|---|---|---|---|
| European Union EU | Restricted | 1Open record 1 | Complete annex dataset Regulation (EC) 1223/2009 consolidated to 1 May 2026 | Review every linked record and exact conditions. |
| Great Britain GB | Prohibited | 2Open record 1Open record 2 | Complete consolidated annex dataset GB retained Regulation 1223/2009 schedules, effective 15 August 2026 | Review every linked record and exact conditions. |
| Canada CA | Restricted | 1Open record 1 | Complete Hotlist snapshot Health Canada Cosmetic Ingredient Hotlist, 13 August 2025 | Review every linked record and exact conditions. |
| New Zealand NZ | Prohibited | 2Open record 1Open record 2 | Complete schedules dataset Cosmetic Products Group Standard schedules effective 1 January 2026 | Review every linked record and exact conditions. |
| ASEAN ASEAN | Restricted | 1Open record 1 | Complete regional annex dataset ASEAN Cosmetic Directive annexes 2026-1, 22 June 2026 | Review every linked record and exact conditions. |
| China CN | Prohibited | 1Open record 1 | Complete prohibited catalogues plus official-source workflow NMPA 2021 banned catalogues plus dynamic IECIC List I/List II system current since 2025 | Review every linked record and exact conditions. |
| Japan JP | No local match | 0 | Complete Standards appendices dataset MHLW Standards for Cosmetics official English source and Japanese amendments checked for the imported snapshot | The Japanese text and subsequent notices are canonical; no local match is not a product-compliance conclusion. |
| South Korea KR | No local match | 0 | Complete current appendix dataset MFDS Notice 2026-19, effective 18 March 2026 | Korean source wording is canonical and other positive lists/notices may still apply to the formulation. |
| United States US | No local match | 0 | Complete enumerated federal ingredient rules eCFR Title 21 issue date 27 August 2026 | FDA has no general approved-cosmetic-ingredient catalogue; absence from these sections is not approval or proof of safety. |
| Australia AU | No local match | 0 | Complete cosmetic-relevant Poisons Standard subset plus official workflow Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 | An AICIS Inventory match is not cosmetic approval; no Inventory match can indicate a new, exempted, reported or confidential introduction. |
| Brazil BR | Prohibited | 1Open record 1 | Complete prohibited dataset plus current restricted-list workflow ANVISA RDC 1.029/2026 and RDC 1.030/2026, published 15 June 2026 | Review every linked record and exact conditions. |
| India IN | Prohibited | 2Open record 1Open record 2 | Complete current Part 2 dataset plus official workflow for Parts 1, 3 and 4 Cosmetics Rules 2020 plus current BIS IS 4707 parts (1:2020, 2:2025, 3:2025, 4:2022) | Review every linked record and exact conditions. |
| Saudi Arabia SA | Prohibited | 2Open record 1Open record 2 | Complete official list index SFDA live prohibited/restricted lists, snapshot 30 August 2026 | Review every linked record and exact conditions. |
No market rows match this filter.
Matching market records and conditions
Great Britain
GB retained Regulation 1223/2009 schedules, effective 15 August 2026Hydroxy-8-quinoline and its sulphate bis(8-hydroxyquinolinium) sulphate, except for the uses of the sulphate provided for in entry 51 of Annex IIIProhibited
GB Cosmetics Regulation, Annex II, entry 395 · 2026-08-15
Oxyqui-noline sulphateRestricted
Stabilizer for hydrogen peroxide
in rinse-off hair products · (0,3% as base)
GB Cosmetics Regulation, Annex III, entry 51 · 2026-08-15
Canada
Health Canada Cosmetic Ingredient Hotlist, 13 August 2025New Zealand
Cosmetic Products Group Standard schedules effective 1 January 2026Hydroxy-8-quinoline and its sulfate bis(8-hydroxyquinolinium) sulfate, except for the uses of the sulfate provided Schedule 5, entry 52Prohibited
Schedule 4, reference 395, source row 414 · effective-2026-01-01
Bis(8-hydroxyquinolium) sulfate (quinolin-8-ol sulfate)Restricted
Product scope: (a) Stabilizer for hydrogen peroxide in rinse-off hair-care preparations (b) Stabilizer for hydrogen peroxide in non-rinse-off hair care preparations · Maximum concentration: (a) 0.3% calculated as base (b) 0.03% calculated as base
Schedule 5, reference 51, source row 73 · effective-2026-01-01
ASEAN
ASEAN Cosmetic Directive annexes 2026-1, 22 June 2026China
NMPA 2021 banned catalogues plus dynamic IECIC List I/List II system current since 2025Brazil
ANVISA RDC 1.029/2026 and RDC 1.030/2026, published 15 June 2026India
Cosmetics Rules 2020 plus current BIS IS 4707 parts (1:2020, 2:2025, 3:2025, 4:2022)Hydroxy-8-quinoline and its sulphate bis(8-hydroxyquinolinium) sulphate, except for the uses of the sulphate provided for in No 53 in Annex B (CAS No. 148-24-3/134-31-6)Prohibited
Must not form part of the composition of cosmetic products. Apply the general trace and safety notes published after Annex A.
IS 4707 (Part 2):2025 Annex A, entry 390 · IS 4707 (Part 2):2025, fifth revision
um) sulphate Oxyqui- noline sulphate (CAS No. /134-31-6)Restricted
Field of application/use: a)Stabilizer for hydrogen peroxide in rinse-off hairs products; and b)Stabilizer for hydrogen peroxide in non-rinse off hair products | Maximum authorised concentration: a)0.3 percent (as base) and b)0.03 percent (as base)
IS 4707 (Part 2):2025 Annex B, entry 51 · IS 4707 (Part 2):2025, fifth revision
Saudi Arabia
SFDA live prohibited/restricted lists, snapshot 30 August 2026Hydroxy-8-quinoline and its sulphate bis(8-hydroxyquinolinium) sulphate, except for the uses of the sulphate provided for in entry 51 of Annex IIIProhibited
SFDA prohibited list, page 40, row 6 · live-snapshot-2026-08-30
bis(8-hydroxyquinolinium) sulphateRestricted
SFDA restricted list, page 7, row 3 · live-snapshot-2026-08-30
Exact Annex II–VI evidence
Annex IIIentry 51
Open full regulatory recordOXYQUINOLINE SULFATE
Product scope: (a) Stabilizer for hydrogen peroxide in rinse-off hair products (b) Stabilizer for hydrogen peroxide in leave-on hair products
Maximum concentration: (a) (0,3 % as base) (b) (0,03 % as base)
Chemical identity and properties
CAS 134-31-6PubChem CID 517000
Hydroxyquinoline sulfate
- IUPAC name
- bis(quinolin-8-ol);sulfuric acid
- Molecular formula
- C18H16N2O6S
- Molecular weight
- 388.4 g/mol
- Exact mass
- 388.07290741 Da
- Topological polar surface area
- 149.0 Ų
- Hydrogen-bond donors
- 4
- Hydrogen-bond acceptors
- 8
- Covalent units
- 3
- Defined stereocentres
- 0
Also known as
8-Hydroxyquinoline sulfateOxyquinoline sulfateOxine sulfateoxyquinoline sulphate8-Quinolinol sulfate (2:1) (salt)61VUG75Y3PCRIPTONOLSulfate, Oxyquinoline
16 more reported names
RefChem:5484218 Hydroxyquinoline SulfateSulfate, 8-Hydroxyquinoline205-137-1AlbisalCryptonolHappyOctofenQuinosol ExtraSolvochin-ExtraSunoxol8-Quinolinol sulfate8-Hydroxy-chinolin-sulfatOxyquinoline sulfate [USAN]Oxychinolinsulfat8-HYDROXYQUINOLINE HEMISULFATE
External database identifiers
- ChEBI:CHEBI:81774
- ChEMBL:CHEMBL1697698
- EPA DTXSID:DTXSID6025436
Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.
CAS 148-24-3PubChem CID 1923
8-Hydroxyquinoline
Quinolin-8-ol is a monohydroxyquinoline that is quinoline substituted by a hydroxy group at position 8. Its fungicidal properties are used for the control of grey mould on vines and tomatoes. It has a role as an antibacterial agent, an iron chelator, an antiseptic drug and an antifungal agrochemical. It derives from a hydride of a quinoline. — ChEBI
- IUPAC name
- quinolin-8-ol
- Molecular formula
- C9H7NO
- Molecular weight
- 145.16 g/mol
- Exact mass
- 145.052763847 Da
- XLogP3
- 2.0
- Topological polar surface area
- 33.1 Ų
- Hydrogen-bond donors
- 1
- Hydrogen-bond acceptors
- 2
- Covalent units
- 1
- Defined stereocentres
- 0
Also known as
8-quinolinolOxyquinolineOxineQuinophenolOxychinolinPhenopyridine8-QuinolBioquin
16 more reported names
TumexOxinOxybenzopyridineHydroxybenzopyridine8-Oxyquinoline1-Azanaphthalene-8-ol8-Hydroxychinolin8-Chinolinol8-Hydroxy-chinolinFennosan H 30Fennosano-OxychinolinUsaf ek-794OxyquinolQuinoline, 8-hydroxy-NCI-C55298
External database identifiers
- ChEBI:CHEBI:48981
- ChEMBL:CHEMBL310555
- EPA DTXSID:DTXSID5020730
- PubMed:23061283
- PubMed:23036464
- PubMed:22999464
- PubMed:22995204
- PubMed:22974321
- PubMed:22956008
- PubMed:22946839
- PubMed:22905728
- PubMed:22876610
- PubMed:22873526
- PubMed:22847630
- PubMed:22833217
Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.
Additional authoritative substance research
These source-specific lookups can add hazard, toxicology, identity and assessment context. A link is a research route, not a claim that the source contains an exact record.
Cosmetic Ingredient Review safety assessments
Expert Panel conclusions, assessed ingredient groups, use conditions, dates and report documents
Independent expert review considered by FDA; not a government approval or binding market rule
Research this identityFDA Global Substance Registration System
UNII identifiers, preferred names, substance types, codes and public substance relationships
Identity registry only; UNII availability does not imply FDA review or approval
Research this identityILO/WHO International Chemical Safety Cards
Hazards, symptoms, first aid, storage, incompatibilities and physical properties for covered chemicals
International occupational chemical-safety reference; not cosmetic-use approval
Research this identityJapan NITE-CHRIP
Chemical identity, Japanese and foreign legal lists, GHS hazards and exposure-related information
Chemical-management evidence; cosmetic status remains governed by the applicable MHLW standard and market rules
Research this identityNIOSH Pocket Guide to Chemical Hazards
REL, PEL, IDLH, properties, exposure routes, symptoms, target organs, first aid and measurement methods for covered workplace chemicals
US occupational-health guidance and limits; not a cosmetic ingredient decision
Research this identityOECD eChemPortal
Gateway to authority-owned physical-property, fate, ecotoxicity, toxicity, exposure and GHS records
Discovery gateway; each linked authority remains responsible for its data
Research this identityUS EPA CompTox CTX APIs
DTXSID identity, experimental and predicted properties, toxicity, bioactivity, exposure and environmental data
Scientific and computational evidence; predictions must remain labelled and do not determine cosmetic legality
Research this identityContinue the compliance check
1. Confirm identity
Match the supplier specification, CAS/EC identifiers and composition to this official label name. Similar wording is not proof of chemical equivalence.
2. Review restrictions
Check every exact Annex record shown above, plus CMR, nanomaterial, SCCS and later-amendment requirements that may apply.
3. Verify the formula
Evaluate concentration, product type, purity, warnings, claims and each target market before making a compliance decision.
Official source and scope
Imported from Commission Implementing Decision (EU) 2025/1175 (dataset version EU 2025/1175). The glossary supplies common ingredient names for the ingredient list required by Article 19(1)(g); it is not an approval or safety list.
Open official Decision